Advertisement
CAH vs MCK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and MCK is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CAH’s FA Score shows that 2 FA rating(s) are green whileMCK’s FA Score has 3 green FA rating(s).
- CAH’s FA Score: 2 green, 3 red.
- MCK’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CAH’s TA Score shows that 3 TA indicator(s) are bullish while MCK’s TA Score has 5 bullish TA indicator(s).
- CAH’s TA Score: 3 bullish, 5 bearish.
- MCK’s TA Score: 5 bullish, 3 bearish.
Price Growth
CAH (@Medical Distributors) experienced а +0.03% price change this week, while MCK (@Medical Distributors) price change was -0.50% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +0.26%. For the same industry, the average monthly price growth was +6.92%, and the average quarterly price growth was -0.94%.
Reported Earning Dates
CAH is expected to report earnings on Oct 31, 2025.
MCK is expected to report earnings on Nov 04, 2025.
Industries' Descriptions
@Medical Distributors (+0.26% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| CAH | MCK | CAH / MCK | |
| Capitalization | 27.3B | 70.5B | 39% |
| EBITDA | 1.89B | 4.44B | 43% |
| Gain YTD | 40.585 | 27.324 | 149% |
| P/E Ratio | 44.47 | 24.25 | 183% |
| Revenue | 216B | 302B | 72% |
| Total Cash | 4.59B | 1.98B | 232% |
| Total Debt | 4.72B | 7.61B | 62% |
CAH | MCK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 79 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | 5 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 4 | 22 | |
P/E GROWTH RATING 1..100 | 92 | 47 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCK's Valuation (11) in the Medical Distributors industry is somewhat better than the same rating for CAH (67). This means that MCK’s stock grew somewhat faster than CAH’s over the last 12 months.
CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is in the same range as MCK (5). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.
CAH's SMR Rating (99) in the Medical Distributors industry is in the same range as MCK (99). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.
CAH's Price Growth Rating (4) in the Medical Distributors industry is in the same range as MCK (22). This means that CAH’s stock grew similarly to MCK’s over the last 12 months.
MCK's P/E Growth Rating (47) in the Medical Distributors industry is somewhat better than the same rating for CAH (92). This means that MCK’s stock grew somewhat faster than CAH’s over the last 12 months.
| CAH | MCK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 60% | N/A |
| Stochastic ODDS (%) | 1 day ago 58% | 1 day ago 41% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 63% | 1 day ago 47% |
| TrendWeek ODDS (%) | 1 day ago 46% | 1 day ago 38% |
| TrendMonth ODDS (%) | 1 day ago 59% | 1 day ago 64% |
| Advances ODDS (%) | 13 days ago 67% | 3 days ago 66% |
| Declines ODDS (%) | 8 days ago 46% | 8 days ago 39% |
| BollingerBands ODDS (%) | 1 day ago 44% | 1 day ago 89% |
| Aroon ODDS (%) | 1 day ago 59% | 1 day ago 73% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| WBIL | 32.28 | 0.12 | +0.38% |
| WBI BullBear Quality 3000 ETF | |||
| USSG | 56.94 | 0.05 | +0.09% |
| Xtrackers MSCI USA Selection Eq ETF | |||
| LFAI | 125.51 | N/A | N/A |
| LifeX 2050 Longevity Income ETF | |||
| LTCN | 7.12 | -0.04 | -0.56% |
| Grayscale Litecoin Trust (LTC) | |||
| CEF | 30.19 | -0.26 | -0.85% |
| Sprott Physical Gold and Silver Trust | |||
CAH and
Correlation & Price change
A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.